DMSO

now browsing by category

Posted by: admin | Posted on: March 31, 2026

DMSO — The Forgotten Remedy Revolutionizing Eye Healing

Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/03/30/dmso-for-eye-health.aspx

Analysis by A Midwestern Doctor March 30, 2026

Story at-a-glance

DMSO is an “umbrella remedy” capable of treating a wide range of challenging ailments due to its combination of therapeutic properties (e.g., reducing inflammation, improving circulation, and reviving dying cells)
DMSO has a unique affinity for the eyes, resulting in it (often spontaneously) treating a wide range of visual disorders that frequently cannot be treated with conventional therapeutic options — including blindness
DMSO’s ability to heal the skin, moisten tissue, and relax muscles makes it excellent for reducing eye strain. It helps heal a variety of challenging conditions around the eyes, such as blepharitis, styes, psoriasis, burns, bags under the eyes, and eye twitches
DMSO’s anti-inflammatory and antimicrobial properties allow it to treat a variety of infections and inflammatory conditions damaging the surface of the eyes (e.g., shingles or keratitis), in many cases facilitating a complete recovery of the eye
DMSO’s ability to heal tissue from injury also allows it to heal damaged eyes, which in many cases would otherwise require the eye to be removed. This article will review how DMSO is able to treat these conditions and how those healing properties allow it to treat many other challenging eye conditions, such as vision loss, macular degeneration, cataracts, and floaters

Dimethyl sulfoxide (DMSO) is a simple compound with a remarkable blend of therapeutic properties that allows it to treat a wide range of conditions including:

• Numerous neurological disorders (e.g., strokes, dementia, paralysis, neuropathies, Down syndrome, and circulatory disorders (e.g., Raynaud’s, varicose veins, hemorrhoids)) — are discussed here.

• Tissue injuries, such as sprains, concussions, burns, surgical incisions, and spinal cord injuries — are discussed here.

•Chronic pain (e.g., from a bad disc, bursitis, arthritis, or complex regional pain syndrome) — are discussed here.

• Autoimmune, protein, and contractile disorders, such as scleroderma, amyloidosis, and interstitial cystitis — are discussed here.

• Head conditions, such as tinnitus, dental problems, and sinusitis — are discussed here.

• Internal organ diseases (e.g., prostate enlargement, pancreatitis, and cirrhosis) — are discussed here.

• Respiratory disorders, including asthma, COPD, and pulmonary fibrosis — are discussed here.

• Many different gastrointestinal disorders, such as bowel inflammation, cirrhosis, and pancreatitis — are discussed here.

• Skin conditions (e.g., hair loss, varicose veins, acne, ulcers, skin cancer, or psoriasis) — are discussed here.

• Infections, such as onychomycosis, herpes, and shingles, are remarkably treatable when combined with an antimicrobial agent — are discussed here.

• Many aspects of cancer (e.g., eliminating cancers, enhancing chemotherapy, and reducing the toxicity of mainstream cancer treatments) — are discussed here.

Because of how effective DMSO was for a wide range of “incurable” conditions, when it was discovered in the 1960s, it rapidly took America by storm and became the most demanded drug in the country — at which point the FDA did everything they could to suppress it (e.g., see this 1980 segment 60 minutes did on DMSO). Regretfully, this was successful, and decades later, DMSO’s remarkable properties, which could have reshaped medicine, were largely forgotten.

However, due to the new political climate we entered — widespread loss of trust in medical authorities and the mass media for their handling of COVID-19 (which allowed the alternative media to rise to prominence) — an unprecedented window was created for unorthodox therapies to gain prominence. As such, over the last year, my attempts to promote the vast body of evidence behind DMSO went viral, and there is now a similar interest in DMSO to what was seen in the 1960s.

Because of this, I have now received over 5,000 reports from readers¹ who’ve benefitted from DMSO (which I compiled here), most of which match the effects typically attributed to DMSO (rapid healing from an injury and/or elimination of debilitating pain). However, I also come across some that are quite extraordinary, such as this 75 year old man who regained sight in his eye after being blind since birth after using DMSO to eliminate a chronic sinus infection.

Video Link

Note: The journalist who filmed this interview previously filmed her neighbor with terminal COPD recovering with nebulized DMSO.

Murray’s story (and hundreds more I’ve received from readers) illustrates one of the least appreciated facets of DMSO — it is exceptionally well suited to treating a wide range of eye conditions — many of which are considered incurable within conventional medicine.

Note: The German DMSO community (including DMSO utilizing ophthalmologists) has reported very similar results to those shared with me by readers when using DMSO to treat the eyes.

DMSO and the Eyes

“Ophthalmologist Norbert J. Becquet, M.D. reported in May 1980 that he had great success using DMSO in treating cataracts and other eye problems. ‘I’ve treated two hundred patients in the last year for macular degeneration, macular edema, and traumatic uveitis.’”

Note: DMSO has been repeatedly shown to enhance the penetration of drugs into the eyes,^2,3,4,5 potentiate certain ocular medications (e.g., anesthetic eye drops⁶ or 5-IDU to treat shingles)⁷ and authors have proposed using these combinations to enhance the efficacy of ophthalmologic medications and bypass the need to inject them into the eyes.⁸ Likewise, doctors like Norbert Becquet used topical DMSO nutraceutical combinations to treat otherwise “incurable” eye conditions.⁹

DMSO’s uses for the eyes originally emerged after participants in early clinical trials noted that their vision frequently improved when an unrelated issue was being treated (due to DMSO’s tendency to concentrate within the eyes). Likewise, readers here have frequently reported that vision significantly improves after DMSO is applied to another part of the body — particularly the neck (which is likely due to its blood supply being closer to the eyes).

Note: Due to the intense scrutiny DMSO was subjected to, its safety within the eyes was extensively studied — after which no one detected eye toxicity. For example, a JAMA publication attested to DMSO’s eye safety,¹⁰ and in a study where DMSO was applied to the eyes of 108 patients¹¹ — including those with numerous pre-existing eye diseases — no side effects occurred besides a concentration dependent temporary irritation of the eyes.

I will now review how DMSO makes it suited to treat a wide range of disorders on the surface of the eyes.

Peripheral Eye Issues

“My mother (100 yrs old) fell three weeks ago.¹² When she fell, she broke her nose and fractured a couple of orbital bones — one around each eye — which resulted in terrible black bruising due to her blood thinner medication. She spent 6 days in the hospital and my sister and I visited her everyday. After applying daily DMSO, the bruises rapidly changed color, and in three days they began to fade and then completely disappeared.”

Due to DMSO’s ability to rapidly heal injuries, relax muscles, and reduce skin inflammation, it is well-suited for treating a wide range of issues around the eyes. Studies in turn have shown:

• DMSO combined with iodine safely treated inflammatory eye conditions^13,14,15,16 (e.g., in 17 patients with blepharitis and blepharoconjunctivitis all had a partial or complete response to it¹⁷).

• In children with eyelid styes, DMSO reduced swelling and pain.¹⁸

• DMSO treated inflammatory diseases of the eyelids.¹⁹

“I have a really complicated eye history [including] having blepharitis many times that left my eyelids inflamed for a very long time.²⁰ I’ve now had inflammation on my eyelids for over a year. It’s almost gone in [after] about a week of DMSO.”

Likewise, many readers have reported DMSO treats issues around the eyes (e.g., for bags and wrinkles,²¹ blepharitis,^22,23,24 psoriasis,^25,26 styes,^27,28,29 burns,^30,31 milia,³² cellulitis,³³ skin tags, and pedicules,^34,35).

“After reading your articles I tried DMSO on a huge eye stye my husband has, a recurring issue that no doctor had been able to fix.³⁶ In less than 24 hours it went from the size of a large pea to near gone.”

“I have used DMSO even on the lower lids of my eyes, at 25%, with astonishing success in treating a chemical/heat burn [hot tar while fighting a fire] that troubled me for about ten years, AND IT RESOLVED ABRUPTLY.”³⁷

Finally, DMSO’s ability to relax muscles likely accounts for many of its therapeutic properties (e.g., chronically tight muscles distort focusing and many readers have reported they no longer needed to wear eye glasses after using DMSO). Likewise:

• One reader reported being able to treat superior oblique myokymia, a rare “untreatable” eye condition where that muscle will spontaneously twitch, distorting vision, fatigue the eyes, and making it impossible to drive.³⁸

• James Miller M.D. has reported successfully curing chronic eye twitches with DMSO.³⁹

• Using DMSO in conjunction with eye exercises has been reported to dramatically improve their efficacy.

Corneal and Conjunctival Disorders

DMSO’s therapeutic properties and its tendency to concentrate within the cornea make it well-suited to healing issues at the surface of the eyes, particularly since DMSO, being an acetylcholine esterase inhibitor, also stimulates parasympathetic activity (which increases tear secretion) and reduces duct inflammation or obstruction (also increasing tear secretion).

Because of this, many readers have reported remarkable results for eye dryness^{40,41,42,43,44,45,46,47,48,49,50,51} (including severe cases from Parkinson’s,⁵² severe mast cell activation disorder which had eroded the surface of the cornea,⁵³ or previous chemotherapy⁵⁴).These include:

“I have suffered from severe dry eye for years.⁵⁵ (I’ve had to have Meibomian Gland Probing done twice for my condition, in addition to numerous other treatments). I am having a [very] positive experience using daily DMSO eye drops, I find I need much less commercial eye drops and I am very hopeful about the continued benefit of the DMSO drops.”

“It takes care of my chronic dry eyes for 6 to 8 hrs.”⁵⁶

“I no longer have dry eye syndrome in that eye.”⁵⁷

“I’ve been using DMSO in my eyes for more than a year now. Slowly increasing the strength.⁵⁸ Even at [low doses] it’s life changing! No more dry eyes or eye infections. Better vision. For anyone who is hesitant, start slowly and ‘see’ 🤣 the amazing results.”

Likewise, many readers have also reported less blurriness,^59,60,61 reduced eye strain^62,63,64 (particularly from screens), and the eyes feeling refreshed.^65,66 I have also seen numerous reports of DMSO healing debilitating corneal injuries like this readers:

“For decades, I experienced mysterious, intermittent left eye pain [which] contributed to regular severe sleep disruption.⁶⁷ After seeing 12 doctors, they finally discovered I had corneal injury from a piece of glass getting stuck in there for a few days in 1974, but had nothing to offer me. After starting DMSO because of your article, the pain finally went away and I could sleep. Tests this week also showed the eye’s tear production recovered. Thank you AMD!”

Note: I have also received reports of DMSO rapidly treating conjunctivitis,⁶⁸ a conjunctival cyst,⁶⁹ and a pterygium⁷⁰ (which incidentally resulted from applying DMSO to the neck).

DMSO’s unique properties (e.g., its ability to remove edema and pathologic protein deposits) can also address a few challenging corneal issues for which there are currently no viable therapeutic options. For example:

• Gelatinous drop-like corneal dystrophy is a rare genetic eye disorder where amyloids build up just beneath the corneal epithelium (progressively clouding it, and impairing vision) that is difficult to treat (requiring corneal transplantation once it progresses — which can then be followed by recurrences). Extensive research shows DMSO eliminates amyloids, and in one case report,⁷¹ DMSO was found to eliminate the amyloid which had accumulated after a corneal transplant.

• One of the early DMSO studies repeatedly found DMSO treated corneal edema.⁷²

• Likewise, three readers shared they used it for Fuchs’ dystrophy (an incurable eye disorder where the cornea swells with fluid, causing gradual vision loss). Of them, one reported it significantly reduced corneal edema and improved their vision, one reported the same (but did not have a formal diagnosis), while a third reported they’d begun trying it, but weren’t yet sure if it was helping.^73,74

• One reader reported DMSO rapidly cleared a corneal deposit in her 15-year-old Boston terrier.

Finally, in both the reports I received and those I’ve seen throughout the DMSO community, users frequently report that DMSO “cleans their eyes out” and makes vision much sharper and clearer. This likely comes from DMSO removing insoluble protein aggregates (from the cornea, lens, or vitreous) or its reviving retinal function — something DMSO is uniquely suited to do in a noninvasive manner.

Note: DMSO has a unique ability to refold and eliminate misfolded proteins (e.g., amyloids), including opaque ones that accumulate within the eyes. In turn, one of the most common things readers report is DMSO treating floaters (and in almost all cases, the treatment being successful), followed by cataracts — which likely accounts for many of the instances where DMSO appears to clean the eyes out.

Additionally, one reader noted this clearing of the eyes could be externally observed with (as the sickly look hadn’t returned), suggesting DMSO can increase the eye’s ability to absorb the critical spectrums in natural light (particularly since other studies have shown DMSO increases the skin’s ability to transmit light).

Inflammatory and Infectious Conditions

DMSO’s potent anti-inflammatory and antimicrobial properties make it well suited for treating a variety of conditions throughout the eye and often to do so in a safer and more potent manner than existing treatments (e.g., in one clinical trial, 30% DMSO was found to have therapeutic anti-inflammatory effects on the eye similar to 0.01% dexamethasone⁷⁵).

In turn, numerous studies show DMSO eliminates challenging inflammation and infection on the surface of the eye. For example, DMSO has repeatedly been shown to be an effective treatment for chronic superficial keratitis (CSK), which over time, can reduce eye inflammation without any adverse effects to the corneal epithelium^76,77 and in many cases, to be a superior CSK treatment to steroids.^78,79 For example:

• In dogs with CSK, 50% DMSO combined with dexamethasone or prednisolone was found to be a much more effective treatment than either alone (e.g., it effectively reduced corneal inflammation and improved corneal transparency).^{80,81,82,83,84}

chronic superficial keratitis with dexamethasone or prednisolone

• In dogs, DMSO has also been shown to safely treat CSK in combination with cyclosporine.⁸⁵ Significant benefit has also been seen from combining DMSO with both dexamethasone and cyclophosphamide (e.g., a 77.9% to 90.7% reduction in neovascularization, a 45% to 51% reduction in corneal surface inflammation, 72.9% of corneas had a reduction in pigmentation, 74.3% had an increase of transparency, and 95.4% had a repigmentation of the nictitating membrane).⁸⁶

chronic superficial keratitis with cyclosporine

Note: Another dog CSK study found DMSO and tacrolimus halved inflammatory infiltration and neovascularization of the cornea,⁸⁷ while another found similar results with picrolimus and DMSO.⁸⁸

Likewise, DMSO and penicillin treated calves infectious keratoconjunctivitis.⁸⁹

• Topical DMSO and itraconazole was able to resolve chronic (fungal) keratomycosis in 80% of treated horses.⁹⁰

• Likewise, a horse with fungal ulcerative keratitis fully recovered with DMSO and fluconazole.^91,92

Note: DMSO has been extensively shown to treat ocular inflammation (e.g., uveitis, iritis, and episcleritis) and associated complications (e.g., synechia).

Eye Injuries and Trauma

DMSO has been repeatedly shown to protect tissue throughout the body from a variety of injuries, and does the same for the eyes:

• In rabbits, 3 days, 20% DMSO was found to significantly reduce the corneal opacification and ulcerations that followed alkali burns.⁹³

• In multiple studies, DMSO was found to be an effective treatment for corneal acid burns from hydrofluoric acid^94,95 (and also for hydrofluoric acid burns on other parts of the body).⁹⁶

• In another study,⁹⁷ DMSO was combined with monomycin to treat corneal burns.⁹⁸

Likewise, many readers have reported that DMSO has healed a variety of eye injuries:

“I was kicked in my eye by our puppy, 50 lbs and strong, did serious damage and was legally blind seeing double, no progress healing for a month.⁹⁹ So I found a DMSO recipe and my vision was restored. I’m no expert, it worked for me and quick. I had 80% healing in days, a good part of that in 24 hours. Month previous, as stated, I was not improving at all.”

“Many years ago my mother-in-law burst a blood vessel in her eye.¹⁰⁰ After trying allopathic approaches with the MD, we made her [eye] drops containing DMSO. In mere days, the eye returned to normal.”

Likewise, a month ago, a friend injured their eye by cliff jumping from quite a height and not shielding their eye when they hit the water (resulting in the eye being filled with blood). Once my friend decided to use DMSO, we saw the eye rapidly heal and the blood within it leave … after which they repeated the same jump, again did not correctly shield their eye, and then healed the eye again with DMSO.

I have also received numerous remarkable reports of pets with injured eyes that would normally be removed instead have a complete recovery like these:

• This cat had its eye scratched, after which the vet said the necrotic eye needed to be urgently removed.¹⁰¹ While they raised money for the operation, they tried flushing the eye with DMSO and colloidal silver roughly every hour (which Gerald the cat loved), the eye rapidly improved, and a few days after the initial visit, the vet cancelled the operation and after six weeks the eye was healed.

• This dog had got an eye ulcer from a scratch, and the vet wanted to remove the (blind) eye.¹⁰² After a month it fully healed and sight returned.

Note: I have received additional reports of injured pet eyes recovering and reports of human eyes that top doctors said would need to be removed instead of recovering with DMSO.

Conclusion

DMSO’s ability to heal the surface of the eye also allows it to heal conditions deeper within the eyes. In turn, it has been truly extraordinary for me to see how much data there is supporting it treating nearsightedness, floaters, cataracts, glaucoma, uveitis, macular degeneration, and other causes of blindness like retinitis pigmentosa — as for many of these conditions, I was trained to believe there was nothing you could ever do to cure them.

Fortunately, due to our extraordinary political climate, more and more are awakening to the Forgotten Sides of Medicine and realizing they can take direct charge of their health rather than depend on a costly, often counterproductive medical system. It has been an incredible privilege to see just how many readers have been able to restore their eyes with DMSO, and we are deeply grateful that we at last can change the unhealthy medical paradigm we’ve been trapped within.

Author’s Note: This is an abridged version of a longer article that discusses the evidence presented here in more detail along with how DMSO can be used with natural therapies to treat a variety of other complex eye disorders (e.g., macular degeneration, floaters, cataracts, or needing to wear glasses). That article, along with additional links and references, can be read here.

A Note from Dr. Mercola About the Author

A Midwestern Doctor (AMD) is a board-certified physician from the Midwest and a longtime reader of Mercola.com. I appreciate AMD’s exceptional insight on a wide range of topics and am grateful to share it. I also respect AMD’s desire to remain anonymous since AMD is still on the front lines treating patients. To find more of AMD’s work, be sure to check out The Forgotten Side of Medicine on Substack.

– Sources and References

¹ See all references

Posted in DMSO, Eyes | No Comments »

Posted by: admin | Posted on: March 30, 2026

The Great Alzheimer’s Scam and the Proven Cures They’ve Buried for Billions

Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2026/03/26/alzheimers-amyloid-hypothesis-fraud.aspx
Analysis by A Midwestern Doctor March 26, 2026

Story at-a-glance

Alzheimer’s disease is commonly thought to result from abnormal plaque buildup in the brain that gradually destroys brain tissue. Almost all Alzheimer’s research for decades has been directed toward eliminating amyloid, even after the basis for much of this work was shown to stem from fraudulent research
The billions spent on amyloid Alzheimer’s research have only produced three drugs, all of which offer minuscule benefits and severe side effects
In contrast, affordable and straightforward treatments that reduce dementia or the preceding cognitive impairment have been maligned and buried by the medical industry
DMSO for example, has incredible neuroprotective qualities that have spared many stroke and spinal cord injury victims from a life of “incurable” disability. Decades of forgotten research also show it treats cognitive impairment and dementia
This article will review the great amyloid scam and the simple therapies for cognitive decline we’re never told about

Medicine is strongly biased towards adopting biochemical models of disease as this facilitates costly therapeutics being developed for each disease and hence sustains the medical industry. Unfortunately, in many cases, the biochemical approach to disease, at best, can manage symptoms, and as a result, many conditions remain “incurable” while non-patentable natural therapies that can cure them languish in obscurity.

That’s why, despite spending an ever increasing amount of money on Alzheimer’s research (e.g., the NIH spent 2.9 billion in 2020 and 3.9 billion in 2024¹), we’ve still failed to make any real progress on the disease. This is particularly remarkable given the vast costs to the country (e.g., last year Alzheimer’s was estimated to cost the United States 360 billion dollars²) and the even greater social costs that accompany it.

The Amyloid Juggernaut

In 1906, plaques (of amyloid) in the brain were identified as the cause of Alzheimer’s disease. As the years have gone by, the majority of research for treating Alzheimer’s disease has been targeted at eliminating these plaques. Unfortunately, to quote a 2022 article:³

“Hundreds of clinical trials of amyloid-targeted therapies have yielded few glimmers of promise, however; only the underwhelming Aduhelm has gained FDA approval. Yet Aβ still dominates research and drug development. NIH spent about $1.6 billion on projects that mention amyloids in this fiscal year, about half its overall Alzheimer’s funding.

Scientists who advance other potential Alzheimer’s causes, such as immune dysfunction or inflammation, complain they have been sidelined by the ‘amyloid mafia.’ Forsayeth says the amyloid hypothesis became ‘the scientific equivalent of the Ptolemaic model of the Solar System,’ in which the Sun and planets rotate around Earth.”

Note: Frequently, when a faulty paradigm fails to explain the disease it claims to address, rather than admit the paradigm is flawed, its adherents will label each conflicting piece of evidence as a paradox (e.g., the French “paradox” disproves the notion cholesterol causes heart disease⁴) and dig deeper and deeper until they can find something to continue propping up their ideology (e.g., cholesterol reducing statins provide almost no benefit for heart disease while having significant side effects yet continue being pushed on patients).

The consistent failure of the amyloid model to cure Alzheimer’s gradually invited increasing skepticism towards it, which resulted in more and more scientists studying alternative models of the disease. Before long, they found other factors played a far more significant role in causing the disease (e.g., chronic inflammation), and by 2006, this perspective appeared poised to change the direction of Alzheimer’s research.

In response, the amyloid proponents pivoted to defending their failed hypothesis was due not to amyloid clumps, but rather toxic parts of it (oligomers) and a Nature 2006 paper appeared which identified a previously unknown toxic oligomer, Aβ*56, and provided proof that it caused dementia in rats.⁵

This paper cemented both the amyloid beta and toxic oligomer hypotheses (as it provided the proof many adherents to the theory had been waiting for) and rapidly became one of the most cited works in the field of Alzheimer’s research. Its authors rose to academic stardom, produced further papers validating their initial hypothesis, and billions more were invested by both the NIH and the pharmaceutical industry in research of the amyloid and toxic oligomer hypothesis.

It should be noted that some were skeptical of their findings and likewise were unable to replicate this data, but rarely had a voice in the debate:

“The spotty evidence that Aβ*56 plays a role in Alzheimer’s had [long] raised eyebrows.⁶ Wilcock has long doubted studies that claim to use ‘purified’ Aβ*56. Such oligomers are notoriously unstable, converting to other oligomer types spontaneously. Multiple types can be present in a sample even after purification efforts, making it hard to say any cognitive effects are due to Aβ*56 alone, she notes — assuming it exists.

In fact, Wilcock and others say, several labs have tried and failed to find Aβ*56, although few have published those findings. Journals are often uninterested in negative results, and researchers can be reluctant to contradict a famous investigator.”

The Amyloid Scandal

At the end of 2021, a neuroscientist physician was hired by investors to evaluate an experimental Alzheimer’s drug and discovered signs that its data consisted of doctored Western Blots (and therefore erroneous assessments of what oligomers were present within research subjects’ brains).⁷ As he explored the topic further, he discovered other papers within the Alzheimer’s literature had been flagged for containing doctored Western Blots.

Note: Western blots, used to test for proteins, are one of the few easily detectable forms of research fraud (e.g., we discovered Pfizer submitted fake Western blots to regulators to “prove” their vaccine worked). Regrettably, far more undetectable fraud exists throughout the scientific literature (e.g., independent researchers comparing regulatory submissions discovered Pfizer also submitted doctored data on where the COVID vaccine is distributed in the body⁸).

Before long, the neuroscientist noticed three of those suspect papers had been published by the same author and decided to investigate the author’s other publications. This led him to the seminal 2006 Alzheimer’s publication, which contained clear signs of fraud.⁹

As investigation then uncovered 20 doctored papers written by the author, 10 of which pertained to Aβ*56 (along with a co-researcher attesting to earlier scientific misconduct by the author).

The Amyloid Industry

One of the remarkable things about this monumental fraud was how little was done about it. For example, the NIH was notified in January 2022, yet in May 2022, beyond nothing being done, the NIH gave the suspect researcher a coveted $764,792 research grant (signed off by another one of the authors of the 2006 paper¹⁰).

In July 2022, Science published an article exposing the incident and the clear fraud that had occurred.¹¹ Despite this, the researcher was allowed to remain in his position as a tenured medical school professor.¹² It was not until June 2024 that the 2006 article was retracted at the request of the authors¹³ — all of whom denied being at fault and insisted the doctored images had not affected the article’s conclusions.

Eventually, on January 29, 2025, during his confirmation hearing, RFK cited the paper as an example of the institutional fraud and wasted tax dollars within the NIH, and a few days later, the suspect researcher announced his resignation from the medical school professorship (while still maintaining his innocence).¹⁴

This odd behavior (e.g., the medical field continues to insist the proven fraud has not disproven the Amyloid hypothesis) likely results from how much money is at stake — beyond the research dollars, roughly 7 million adults have Alzheimer’s — equating to hundreds of billions in potential (Medicare funded) sales each year.¹⁵

The Failed Amyloid Drugs

Recently, a monoclonal antibody that made immune cells target amyloid demonstrated limited success in treating Alzheimer’s — which was embraced as revolutionary by the medical community, the pharmaceutical industry, and drug regulators. In turn, the first new drug received accelerated approval (which the FDA proudly announced).¹⁶ The second then received a quiet backdoor approval (due to the immense controversy surrounding the first),¹⁷ and the third was partially approved a year and a half later.¹⁸

Each year, JP Morgan (Chase Bank) hosts a private conference for pharmaceutical investors that sets the tone for the entire industry. In 2023, its focus (covered in detail here) was on the incredible profitability of the new Alzheimer’s drugs and the GLP-1s like Ozempic (which the FDA has also relentlessly promoted). Most remarkably, the (widely viewed as corrupt) FDA commissioner was a keynote speaker, and a few days before the conference, had enacted the second backdoor approval.

However, despite the rosy pictures painted around the drugs (which each attacked different aspects of amyloids), they were highly controversial as:

• The FDA’s independent advisory panel, in a very unusual move, voted 10-0 (with one abstaining) against approving Aduhelm, the first amyloid drug (which targeted amyloid plaques), but the FDA approved it anyways. In a highly unprecedented move, three of the advisors then resigned, calling it “probably the worst drug approval decision in recent U.S. history.”¹⁹

• That drug was priced at $56,000 a year — making it sufficient to bankrupt Medicare, (which attracted a Congressional investigation).²⁰

• Brain swelling or brain bleeding was found in 41% of patients enrolled in its studies.²¹ Additionally, headaches (including migraines and occipital neuralgia), falls, diarrhea, confusion, and delirium were also notably elevated compared to placebo.

• No improvement in Alzheimer’s was noted; rather one analysis found it slowed the progression of Alzheimer’s by 20% (although this could have been a protocol artifact rather than a real effect).

The second monoclonal antibody (which targeted amyloid precursors) had a somewhat better risk benefit profile²² (only 21% experienced brain bleeding and swelling due to reduced targeting of stable amyloid plaques), and 26.4% reduction in the progression of Alzheimer’s was detected in the trial (which for context, translated to a 0.45 reduction on a scale where a reduction of at least 1 to 2 points is needed to create an impact which is in any way meaningful for a patient).

The third monoclonal (which targeted amyloid plaques thought to be more pathologic)²³ was also contested as it caused 36.8% of recipients to develop brain bleeding or swelling, like the other amyloid medications, frequently caused headaches and infusion reactions (e.g., nausea, vomiting, changes in blood pressure, hypersensitive reactions, or anaphylaxis) and there were reasons to suspect the trial had greatly overstated its minimal benefits.

Remarkably, despite widespread protest against the third drug, the FDA’s new advisory panel voted unanimously in favor of it, even though it had a very similar mechanism, efficacy, and toxicity to the previously unanimously rejected amyloid drug.

It should therefore come as no surprise that, when the British Medical Journal conducted an independent investigation, it found that, within publicly available databases, 9 out of 9 (assessable) members of the advisory committee had significant financial conflicts of interest.²⁴

Fortunately, despite the aggressive promotion of amyloid drugs and the industry’s best attempts to promote the sector, the market somewhat recognized how bad they were. The first drug had its price halved (then was withdrawn as no one wanted it — making around 5 million dollars total),²⁵ while the other two have had very modest sales (e.g., 290 million for the most popular one²⁶).

What Amyloids Drugs Show Us

From this, four things stand out:

• These drugs consistently damage brain tissue, indicating that their mechanism of action was inherently dangerous (e.g., it creates brain swelling by causing immune cells attacking amyloid also to attack brain tissue, or it creates brain bleeding by removing amyloid plaque that patches vessel walls and stabilizes brain tissue). Remarkably, despite this issue being recognized, it has not deterred the usage of these class drugs.

• Removing amyloid offers minimal benefit and may be counterproductive. In fact, one of the only protocols that has had proven success in treating Alzheimer’s instead views amyloid as a protective mechanism the brain uses to prevent further damage.

• An absolutely absurd amount of money and time has been wasted on this endeavor due to the medical field’s need to find a patentable drug.

• The focus on these lucrative drugs has diverted attention from other (off-patent) treatments that are more likely to help Alzheimer’s patients.

For example, a randomized controlled trial which gave MCTs derived from coconut found that over 6 months,²⁷ 80% remained stable or improved — which for context, is better than what any of the amyloid drug trials showed, and more importantly, does not cause brain bleeds (and costs a lot less than the annual rough $30,000 cost for those drugs).

Note: Numerous readers have shared that coconut oil improved their relative’s dementia.

Likewise, very few are aware of a 2022 study that should have revolutionized the entire Alzheimer’s field:²⁸

Note: The RECODE protocol was based around identifying the underlying cause of a patient’s cognitive impairment (as five different things can cause dementia), and then providing appropriate natural therapies to address the applicable cause. Since then, many others have replicated its success in their patients.

DMSO and Dementia

Dimethyl Sulfoxide (DMSO) is a naturally occurring compound that has a variety of unique healing properties that allow it to rescue tissues from dying and revive those damaged from previous injuries — best demonstrated by decades of evidence showing DMSO can heal strokes, brain bleeds, severe concussions, and spinal cord injuries and save patients from a lifetime of paralysis.

As many of DMSO’s mechanisms directly counteract the processes that trigger dementia, I have received many accounts like these from readers:

“My uncle’s wife has dementia and has been unable to speak for over a year. My mom recently visited them and told them about DMSO. He began to give his wife DMSO orally. After two weeks she began to talk again.²⁹

I read the article and began giving it to my 93 year old mother in her juice every morning at the end of November. She has had some form of dementia for over 15 years. Since taking the DMSO, she no longer suffers with severe sundowners. She is more ‘with it’ and can communicate and laugh with us. Her personality is back. She is crossing her legs again and lifting her pinky finger when drinking her coffee. It’s a lot of little things that make a difference.

She is able to understand when I am asking her to use the bathroom. She is more cognitive and has started coloring in her coloring books again.³⁰

I deeply appreciate your posts on DMSO. You helped bring spontaneous interaction back into the life of my father with Alzheimer’s.”³¹

Numerous studies support these experiences:

• When rats had their carotid arteries surgically modified to reduce the blood going to the brain, DMSO prevented both the neuronal damage and the significant loss of spatial memory and learning that otherwise occurred.³²

• In a similar study, rats who developed persistent and severe memory impairment from reduced brain blood flow received DMSO and FDP for 7 days, which improved their memory by 54%, nearly reaching the cognitive function rats whose blood flow was never cut off.^33,34

• In rats, daily DMSO counteracted memory impairment induced by intracerebroventricular STZ infusions,³⁵ while in a similar study,³⁶ DMSO and Ginkgo biloba improved learning and memory in rats given Alzheimer’s disease.

• Drinking minute amounts of DMSO prevented the visual degeneration otherwise seen in rats engineered to have early Alzheimer’s disease.³⁷ In another study of those rats, it protected key brain cells from disappearing and enhanced both their spatial memory and smell (while decreasing their anxiety).³⁸ Likewise, in rats bred to develop cerebellar disorders, DMSO prevented age-related deterioration of certain cognitive functions (e.g., memory and spatial learning).

These results have also been replicated in humans:

• In 18 patients with probable Alzheimer’s after three months, DMSO greatly improved memory, concentration, and communication, alongside a significant decrease in disorientation in time and space.³⁹

• In 104 elderly adults with dementia due to cerebrovascular diseases, concussions, or Parkinson’s, DMSO combined with amino acids significantly improved their cognition and motor function.⁴⁰

• In 100 patients with cerebrovascular diseases (many of whom had dementia),⁴¹ DMSO caused almost all to have their cardiovascular parameters improve and:

“Recovery from the general symptoms was positive; there were favorable changes which were reflected in a feeling of well being, the recovery of agility, changes of mood from depressed to gay, improvement of sleeping, and clearer speech. As regards the ‘focal’ results, accelerated recovery from hemiplegia and hemiparesia was registered. A speedier recovery of speech in cases of defined or indicated aphasia took place.”

Conclusion

The Alzheimer’s story illustrates how medical science’s relentless focus on commercializable products has failed the country. This must be replaced with prioritizing understanding the root causes of the chronic illnesses we face.

Fortunately, now that MAHA can set national health policy and independent media has broken the media’s monopoly over the truth due to the lies we saw throughout COVID-19, more and more are stepping outside the medical orthodoxy to pursue therapies that can actually heal them. An opportunity like this has never existed before, and it is critical each of us brings attention to the need for real medicine before the window to fundamentally change the practice of medicine closes.

Author’s Note: This is an abridged version of a longer article which discusses the actual causes and treatments for Alzheimer’s disease and the cognitive decline which precedes it. That article, along with additional links and references, can be read here. Additionally, a companion article on how DMSO treats neurological injuries (e.g., strokes, brain hemorrhages, traumatic brain injuries, spinal paralysis, and developmental delay) can be read here.

A Note from Dr. Mercola About the Author

– Sources and References

¹ NINDS, Accessed October 2025
² Cure Alzheimer’s Fund, Accessed October 2025
^3, ^6, ^7, ^11, ¹² Science, Volume 377, Issue 6604, 21 July 2022
⁴ Wikipedia, French paradox, Accessed October 2025
^5, ⁹ Nature Volume 440, pages 352-357 (2006)
⁸ A Midwestern Doctor, October 5, 2025
¹⁰ University of Minnesota, 2022
¹³ Wikipedia, Sylvain Lesné, Accessed October 2025
¹⁴ ScienceInsider, 10 February 2025
¹⁵ CDC.gov, August 17, 2024
¹⁶ FDA, Accessed October 2025 (Archived)
¹⁷ UCI MIND, January 6, 2023 (Archived)
¹⁸ FDA, July 2, 2024
¹⁹ Harvard Medical School, June 10, 2021
²⁰ New York Times, December 29, 2022
²¹ Wikipedia, Aducanumab, Accessed October 2025
²² Wikipedia, Lecanemab, Accessed October 2025
²³ Wikipedia, Donanemab, Accessed October 2025
²⁴ BMJ 2024;386:q2010
²⁵ Global News Wire, December 20, 2021
²⁶ Bio World, August 28, 2025
²⁷ Alzheimers Dement (N Y). 2022 Mar 14;8(1):e12259
²⁸ Journal of Alzheimer’s Disease. 2022;88(4):1411-1421
²⁹ A Midwestern Doctor, April 1, 2025
³⁰ A Midwestern Doctor, February 9, 2025
³¹ A Midwestern Doctor, April 10, 2025
³² University of Groningen, 2004
³³ Brain Res. 1998 Jan 1;779(1-2):285-8
³⁴ Neurochemistry. Springer, Boston, MA
³⁵ RMM, 2013, Volume 1, Issue 1, Pages 22-29
³⁶ Acta Academiae Medicinae Zunyi. 2002, (06) (Archived)
³⁷ Investigative Ophthalmology & Visual Science June 2024, Vol. 65, 1384
³⁸ Neuropharmacology, Volume 113, Part A, February 2017, Pages 434-444
³⁹ Department of Neurology & Neurosurgery, Medical University, Kisheinev, 277072, Moldova
⁴⁰ Rev. Hosp. Psiquiátrico (Santiago) 4 (1970)
⁴¹ Amazon, Grismali, J., and Varela, L., “Uso de Ipran en Neurologia,” Rev. Hosp. San Fco.De Borja, Vol. 5, No. 4, Dic. 1970, Santiago, Chile

Posted in Alzheimer's, DMSO, Natural Medicine | No Comments »

Posted by: admin | Posted on: November 30, 2025

From Sharper Night Vision to Curing Lifelong Blindness — How DMSO Heals Each Level of Vision Loss

Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2025/11/28/dmso-reverses-vision-loss-blindness.aspx

Analysis by A Midwestern Doctor November 28, 2025

Story at-a-glance

DMSO is a proven “umbrella remedy” that treats dozens of “incurable” conditions and protects delicate tissues (especially brain and eyes) from otherwise fatal injuries such as a complete loss of blood flow
DMSO has a unique, almost magnetic affinity for the eyes, routinely restoring vision in disorders conventional medicine considers untreatable — including decades-long and lifelong blindness
DMSO shields the retina from ischemic strokes, intense light damage (e.g., staring directly at the sun), and progressive degenerative diseases such as retinitis pigmentosa, glaucoma, and many others covered below
Clinical studies and dozens of reader reports confirm DMSO halts or reverses macular degeneration — often returning eyesight that patients believed was gone forever. Beyond severe disease, DMSO dramatically improves everyday vision: sharper focus, better contrast and night vision, fewer floaters, and many people reduce or eliminate their need for glasses
In extreme but meticulously documented cases — including a man blind from birth for 75 years and others blind for decades after severe trauma — DMSO has rapidly restored functional sight that modern medicine had declared impossible

Dimethyl sulfoxide (DMSO) is a simple compound with a remarkable blend of therapeutic properties. Over the last year, I’ve compiled thousands of studies showing how it treats a wide range of conditions including:

• Neurological disorders such as strokes, dementia, paralysis, and neuropathies (discussed here).

• Circulatory disorders such as Raynaud’s, varicose veins, and hemorrhoids (discussed here).

• Chronic pain (e.g., from disc herniations, bursitis, or complex regional pain syndrome) and tissue injuries, such as sprains, concussions, burns, surgical incisions, and spinal cord injuries (discussed here).

• Autoimmune, protein, and contractile disorders, such as arthritis, scleroderma, amyloidosis, and interstitial cystitis (discussed here).

• Head conditions, such as tinnitus, ear infections, dental problems, and sinusitis (discussed here).

• Internal organ diseases such as prostate enlargement, pancreatitis, and cirrhosis (discussed here).

• Respiratory disorders, including asthma, COPD, and pulmonary fibrosis (discussed here).

• Many different gastrointestinal disorders, such as bowel inflammation, cirrhosis, and pancreatitis (discussed here).

• Skin conditions such as hair loss, acne, ulcers, skin cancer, or psoriasis (discussed here).

• Infections, such as onychomycosis, herpes, and shingles, and many antibiotic-resistant infections (discussed here).

• Many aspects of cancer, including eliminating cancers, enhancing chemotherapy, reducing the toxicity of mainstream cancer treatments, and reducing cancer pain (discussed here).

Because of how effective DMSO was for a wide range of “incurable” conditions, after being discovered in the 1960s, DMSO quickly became the most demanded drug in the country — at which point the FDA did everything they could to suppress it.

Video Link

The FDA succeeded, and DMSO’s incredible utility became largely forgotten. However, due to its remarkable efficacy and the extensive evidence corroborating its medical utility, once I brought attention to DMSO (in a post-COVID world where widespread skepticism exists towards the medical establishment), it rapidly went viral, and there is now a similar interest in DMSO to what was seen in the 1960s.

Because of this, I have now received over 5,000 reports from readers who’ve benefitted from DMSO (which I compiled here),¹ most of which match the effects typically attributed to DMSO (e.g., rapid healing from an injury or eliminating debilitating chronic pain). However, I also come across some that are quite extraordinary, such as this 75 year old man who regained sight in his eye after being blind since birth after using DMSO to eliminate a chronic sinus infection.

Video Link

Murray’s story illustrates one of the least appreciated facets of DMSO — it is exceptionally well suited to treating a wide range of eye conditions — many of which are considered incurable within conventional medicine.

Note: The German DMSO community (including DMSO utilizing ophthalmologists) has also reported that DMSO has an extraordinary affinity for treating a wide range of eye conditions.

DMSO and the Eyes

DMSO’s uses for the eyes originally emerged after participants in early clinical trials noted that their vision frequently improved when an unrelated issue was being treated (as DMSO will concentrate within the eyes) — something many readers have also reported to me. As DMSO has a variety of different therapeutic effects, such as healing tissues, reducing inflammation, eliminating infection, removing protein deposits, or increasing blood circulation and fluid drainage, it is well suited to treating a variety of eye conditions.

As such, numerous studies and hundreds of readers have reported remarkable improvements in the following eye conditions:

• Floaters, cataracts, and other opacities within the eyes

• Myopia, astigmatism, presbyopia, and other focusing problems (allowing many people to reduce or eliminate the need for glasses)

• Dry eyes, blurry vision, and eye strain (especially from screens)

• Eye spasms and muscle twitching

• Glaucoma and elevated intraocular pressure

• Healing from eye surgeries and eliminating adhesions within the eyes

• Growths on or around the eyes (skin tags, chalazia, pterygia, etc.)

• Blepharitis, conjunctivitis, uveitis, and other inflammatory or infectious eye conditions

Note: The extremely high success rate readers have reported for treating floaters is quite noteworthy given the lack of satisfactory conventional treatments for the condition.

In turn, since many of the above conditions can impair vision (along with many more minor ones not mentioned), it is not surprising that many readers have reported visual improvements from DMSO^{2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31} (e.g., many reported improved night vision^{32,33,34,35,36}). Reports include:

“I just dabbed a bit of DMSO on my eyelids and got an immediate improvement. I could see my pool shots so much better.”³⁷

“Vision has improved, and I can read some small text again — The deterioration of vision that I felt at night after a few hours on the screen has lessened.”³⁸

“DMSO immediately helped my eyesight by improving contrast after I just put a little above my ankle.”³⁹

Furthermore, DMSO’s therapeutic properties enable it to reach the retina and optic nerve, thereby directly treating many challenging visual disorders that ophthalmology still struggles to address (e.g., beyond lowering eye pressure, DMSO can directly counteract the degenerative process of glaucoma).

Note: DMSO has also been repeatedly shown to enhance the penetration of drugs into the eyes, allowing lower (safer) doses to be used and to potentially eliminate the need for eye medications to be injected.^{40,41,42,43,44}

Eye Protection

One of DMSO’s most well documented properties is its ability to protect tissues throughout the body from a variety of otherwise lethal stressors, such as heat, cold, radiation, poisons, and a loss of blood flow — which is a key reason why it produces such remarkable results for strokes and other central nervous system injuries.

In turn, many readers have reported remarkable stroke recoveries with DMSO (along with a dog who’d developed a variety of vestibular neurological issues such as uncontrolled eye movements, due to mini strokes which immediately resolved from small amounts of DMSO and magnesium).⁴⁵

Note: Multiple readers have also reported DMSO rapidly resolving the visual disturbances occurring with migraines.^46,47

As the eyes are also nervous tissue, similar effects from DMSO have been repeatedly observed within them:

• Injecting 1.5% DMSO into the eyes of rats subjected to 90 minutes of retinal ischemia (via optic nerve ligature) was found to reduce the number of ganglion cells that died.⁴⁸

Note: One reader reported “I got IV DMSO after an optic nerve stroke and I’m pretty sure it saved my eyesight in that eye.”⁴⁹ Another shared that six weeks after a retinal bleed,⁵⁰ that eye had episodes of partial loss of vision (“grey outs”) which cleared a few minutes after applying DMSO gel to the eyelid of the affected eye, and a third shared DMSO treated a branched retinal vein occlusion in the eye that was no longer responding to standard therapies.⁵¹

• In mice, numerous studies have shown that DMSO treatment protects retinal cells from damage caused by toxic bright light exposure, preserving retinal function and structure (whereas in untreated mice, most retinal cells were damaged or died).^52,53,54,55

Note: A reader who damaged their eyes from excessive sunlight exposure (due to pre-existing inflammation weakening the eye) was able to heal their eyes with DMSO.⁵⁶ Likewise, another reader who damaged their eyes by accidentally staring at the sun for too long (presumably due to sun gazing) also healed their eyes with DMSO.⁵⁷

Finally, in parallel with DMSO’s ability to heal damaged eye tissue, numerous studies have shown that normal doses of DMSO have no toxicity to the retina or optic nerve.

Save This Article for Later – Get the PDF Now

Download PDF

Retinal Diseases

DMSO’s restorative properties make it uniquely suited to treat challenging degenerative eye diseases.

“My son has retinitis pigmentosa. He uses DMSO eyedrops. They help his [eye’s] field of vision.”^58,59

For example, retinitis pigmentosa (RP),⁶⁰ is a genetic disorder that causes gradually increasing visual loss, and is incurable (excluding a rare subset that an $850,000 gene therapy treats about half the time).⁶¹ As such, it immediately caught a few doctors’ attention that their RP patients had their vision improve while receiving DMSO for something else.⁶²

This prompted a preliminary (successful) investigation that found that DMSO applied to the eyes improves RP,⁶³ and then a larger trial of 50 patients with RP or macular degeneration.⁶⁴

There, no retinal toxicity was observed, and 22 (44%) had improved visual acuity, 9 (19%) had improved visual fields, 5 (10%) had improved night vision and 48 (96%) had no further worsening of their vision (which would otherwise be expected in these retinal disorders) — results which are quite extraordinary. This, for example, was one patient in that study:

“When his DMSO treatment was started, this patient could see hand motion only with his right eye, and had a visual acuity of 20/200 (Snellen) in his left eye. Five days later, his vision was measured as 20/70 + 1 in the left eye, and he could count fingers at 5 ft with his right eye. Three months later, his visual acuity was 20/50 in the left eye.

This patient has continued his treatments daily, except for a 1-week trial interval without DMSO. He noted that his vision began to get worse during this interval, and when he restarted treatment, his vision returned to the level he had just before discontinuance. His most recent visual acuity measurement (two years after starting DMSO) is still 20/50 in the left eye, and he can count fingers at 6 ft with his right eye.”

Animal studies have also shown that DMSO prevents retinal vision loss:

• Low doses of DMSO (0.01% in drinking water) protected retinal cells in mice engineered to model RP.⁶⁵

• In RP model mice, from day 4 to day 23 of life, untreated mice experienced a loss of retinal function not seen in normal mice,⁶⁶ whereas DMSO treated mice had those parameters improve — scotopic a-wave amplitudes (-42% vs. +107%), photopic a-wave amplitudes (-8% vs. +65%) photopic b-wave amplitudes (-20% vs. +56%).

• In Alzheimer’s model mice, very low-dose (0.01%) DMSO in drinking water improved early contrast sensitivity deficits and restored normal outer retinal (ELM–RPE) thickness.^67,68

• In Alzheimer’s model mice, 0.01% DMSO in drinking water prevented the visual loss seen early in the disease process and restored the thickness of the retinal pigment epithelium.

• In rats with diabetic retinopathy, subconjunctival injection of 10% and especially 50% DMSO significantly improved retinal function (higher B-wave and flicker ERG amplitudes) and restored retinal thickness.⁶⁹

In parallel, readers have reported a variety of significant visual improvements from DMSO in a variety of eye disorders (e.g., vision loss due to RP, glaucoma, or multiple sclerosis), including many instances where “incurable” macular degeneration (AMD) improved^{70,71,72,73,74,75,76,77,78,79,80,81,82} (or stopped progressing^83,84,85):

“I personally have used eye drops for 6-7 years. It has effectively stopped my macular degeneration.”⁸⁶

“Personally I have used dmso eye drops for three years. My retina doc said my scarring is down 50% with my AMD.”⁸⁷

“I use DMSO eye drops for my macular degeneration, and it brought my sight from 25/40 to 20/25.”⁸⁸

“I [have AMD] and have been using 40% DMSO for three weeks. Before, I was having ink-blot-like hallucinations that severely affected my central vision, to the point where I couldn’t drive at night even with my glasses on. Just three weeks later, I can now drive at night in the rain without wearing glasses at all, and the impairment in my central vision is completely gone.”⁸⁹

“I tested my AMD with an Amsler’s chart earlier this year and my left eye showed distorted lines. After a month of DMSO, I had no more distortions.”⁹⁰

“My husband has macular degeneration and he is using DMSO. It’s been about four months and his vision has not gotten worse, I think it’s improving. He’s driving better.”⁹¹

“I now use the drops for my macular degeneration. Have great results.”⁹²

Note: Most of the reports I’ve seen on macular degeneration were improvements of the more common (dry) form. Some evidence also suggests it can help wet macular degeneration by inhibiting VEGF and the formation of new blood vessels, which underlie many eye diseases.^93,94,95,96

Additionally, DMSO has also been reported to heal a variety of other challenging retinal conditions. For example, readers have reported improvement of a macular hole,⁹⁷ a severe macular pucker that had required urgent surgery,⁹⁸ and a torn retina that had previously healed badly.⁹⁹

Reversing Blindness

DMSO’s ability to treat conditions like macular degeneration also allows it sometimes to produce even more remarkable results. For example, when I initially received Murray’s seemingly impossible report that DMSO restored sight in an eye which has been blind for 75 years, I was inclined to believe it as I’d read very similar accounts within the early DMSO literature, such as:¹⁰⁰

• A man who had been blind for more than 30 years after having dynamite explode in his face, who started seeing flashes of light after applying DMSO to the head.

• A man who lost sight in the right eye (along with other functions of the eye like focusing) and gradually lost sight in the other after an almost fatal impact by an automobile while skating down the road.

After trying DMSO for hair loss, he noticed a sensation in the back of his right eye, so Dr. Stanley Jacob (the pioneer of DMSO) decided to apply DMSO to that eye, eventually settling on a high concentration (which stung for several minutes, caused tears, and left the eyes bloodshot for about 20 minutes). After this, sight rapidly returned to the right eye (as demonstrated in a blindfold test), along with him regaining the ability to see color (something his good eye had lost since the accident).

Note: One reader has also reported being able to cure their colorblindness with DMSO.¹⁰¹

• A man who had been blind for many years in one eye (only able to distinguish light and dark) regained his sight in that eye with DMSO (e.g., he demonstrated this by walking unaided in public areas and describing objects and events while his good eye was covered).

• A man who was almost blind (leading to him being entirely dependent on others, like his wife, to take him anywhere, cut his meat, or keep his house clean), after a year on DMSO, regained his sight and no longer needed assistance to do anything (which was of great relief to his family).

Note: These results led Jacob to test DMSO on a series of patients with incurable blindness, many of whom then had their vision improve.

Conclusion

I’ve spent decades seeking out methods to treat macular degeneration, and seen a few approaches (e.g., intensive nutritional regimens, eye circulation improving regimens or energetic inputs that reawaken dormant retinal cells) “do the impossible” and bring lost sight back to the eyes.

It’s hence quite noteworthy that DMSO is both able to create many of these same therapeutic effects (e.g., by increasing microcirculation to the eyes, it greatly increases the vital nutrition retinal cells receive), and like those therapies, restore vision, but do so in a much more broad and economical way (rather than only targeting one component of vision loss).

“I’ve had countless patients who were already doing all the ‘right’ things with nutrition and weren’t getting better with their pain/autoimmune problems, and then they did well after adding DMSO.” — James Miller MD

More importantly, the fact that DMSO can quickly and easily treat “incurable” conditions like vision loss provide a critical lesson into the myriad of other chronic illnesses we are facing, as the eyes are not the only part of the body affected by the ever increasing circulatory impairments (many of which result from vaccination) and nutritional depletion of the food supply seen throughout society.

The significant health challenges our society faces require doing something different. Fortunately, as things like DMSO’s saga show, the solutions we are searching for already exist.

More importantly, we have reached a unique historical crossroad, as the dire need to fix America’s disastrous healthcare has thrust us into a never-before-seen political climate where large parts of the culture, media, and government support rather than oppose the adoption of these real and affordable pathways to health. It is up to each of us to make the best of this moment and rediscover the forgotten umbrella therapies.

Author’s Note: This is an abridged version of a longer article that discusses the evidence presented here in more detail along with how DMSO can be used in conjunction with natural therapies to treat the conditions discussed in this article (e.g., macular degeneration) along with a variety of other eye disorders (e.g., floaters, cataracts, glaucoma, nearsightedness, dry eyes, and chronic eye strain). That article, along with additional links and references, can be read here.

A Note from Dr. Mercola About the Author

– Sources and References

¹ See all references

Posted in DMSO, Eyes | No Comments »

Posted by: admin | Posted on: November 22, 2025

DMSO — The Remarkable Compound That Heals the Eye from the Inside Out

Reproduced from original article:
https://articles.mercola.com/sites/articles/archive/2025/11/21/dmso-treats-eye-conditions.aspx

Analysis by A Midwestern Doctor November 21, 2025

Story at-a-glance

DMSO is an “umbrella remedy” capable of treating a wide range of challenging ailments. It has a unique affinity for the eyes, resulting in DMSO frequently treating a wide range of visual disorders that frequently cannot be treated with conventional therapeutic options — including blindness
DMSO’s potent anti-inflammatory properties allow it to treat a variety of challenging inflammatory eye conditions throughout the eye, including uveitis, iridocyclitis, and iritis, along with releasing the troublesome adhesions (synechia) associated with them
DMSO’s ability to restore fluid circulation and protect compromised nerves allows it to rapidly reduce intraocular pressure and protect the optic nerves of glaucoma patients
DMSO’s unique ability to stabilize proteins and solubilize misfolded ones allows it to eliminate a variety of pathologic protein deposits in the eyes, such as floaters and cataracts. Likewise, users often report that their eyes become much sharper and clearer as less obvious deposits are eliminated
DMSO’s ability to normalize the shape of the eyes also frequently results in users reporting their eyes regain the ability to focus and glasses no longer being needed (particularly for nearsightedness). This article will review how DMSO can treat these conditions and how those healing properties allow it to treat many other challenging eye conditions, such as eye strain, dry eyes, vision loss, and macular degeneration